Literature DB >> 14580882

Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation.

Michael R Betts1, Jason M Brenchley, David A Price, Stephen C De Rosa, Daniel C Douek, Mario Roederer, Richard A Koup.   

Abstract

Flow cytometric detection of antigen-specific CD8+ T cells has previously been limited to MHC-class I tetramer staining or intracellular cytokine production, neither of which measure the cytolytic potential of these cells. Here we present a novel technique to enumerate antigen-specific CD8+ T cells using a marker expressed on the cell surface following activation induced degranulation, a necessary precursor of cytolysis. This assay measures the exposure of CD107a and b, present in the membrane of cytotoxic granules, onto the cell surface as a result of degranulation. Acquisition of cell surface CD107a and b is associated with loss of intracellular perforin and is inhibited by colchicine, indicating that exposure of CD107a and b to the cell surface is dependent on degranulation. CD107a and b are expressed on the cell surface of CD8+ T cells following activation with cognate peptide, concordant with production of intracellular IFNgamma. Finally, CD107-expressing CD8+ T cells are shown to mediate cytolytic activity in an antigen-specific manner. Measurement of CD107a and b expression can also be combined with MHC-class I tetramer labeling and intracellular cytokine staining to provide a more complete assessment of the functionality of CD8+T cells expressing cognate T cell receptors (TCR).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14580882     DOI: 10.1016/s0022-1759(03)00265-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  680 in total

1.  Blockade of programmed death-1 pathway rescues the effector function of tumor-infiltrating T cells and enhances the antitumor efficacy of lentivector immunization.

Authors:  Qifeng Zhou; Haiyan Xiao; Yanjun Liu; Yibing Peng; Yuan Hong; Hideo Yagita; Phillip Chandler; David H Munn; Andrew Mellor; Ning Fu; Yukai He
Journal:  J Immunol       Date:  2010-10-06       Impact factor: 5.422

Review 2.  Once a killer, always a killer: from cytotoxic T cell to memory cell.

Authors:  Leo Lefrançois; Joshua J Obar
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

3.  CMV antigen-specific CD4+ and CD8+ T cell IFNgamma expression and proliferation responses in healthy CMV-seropositive individuals.

Authors:  Elizabeth Sinclair; Douglas Black; C Lorrie Epling; Alexander Carvidi; Steven Z Josefowicz; Barry M Bredt; Mark A Jacobson
Journal:  Viral Immunol       Date:  2004       Impact factor: 2.257

4.  An NKG2D-mediated human lymphoid stress surveillance response with high interindividual variation.

Authors:  Seema Shafi; Pierre Vantourout; Graham Wallace; Ayman Antoun; Robert Vaughan; Miles Stanford; Adrian Hayday
Journal:  Sci Transl Med       Date:  2011-11-30       Impact factor: 17.956

5.  Integrin antagonists prevent costimulatory blockade-resistant transplant rejection by CD8(+) memory T cells.

Authors:  W H Kitchens; D Haridas; M E Wagener; M Song; A D Kirk; C P Larsen; M L Ford
Journal:  Am J Transplant       Date:  2011-09-22       Impact factor: 8.086

6.  Melanoma progression despite infiltration by in vivo-primed TRP-2-specific T cells.

Authors:  Vinod Singh; Qingyong Ji; Lionel Feigenbaum; Robert M Leighty; Arthur A Hurwitz
Journal:  J Immunother       Date:  2009 Feb-Mar       Impact factor: 4.456

7.  Personalized ex vivo multiple peptide enrichment and detection of T cells reactive to multiple tumor-associated antigens in prostate cancer patients.

Authors:  Pavla Taborska; Dmitry Stakheev; Zuzana Strizova; Katerina Vavrova; Michal Podrazil; Jirina Bartunkova; Daniel Smrz
Journal:  Med Oncol       Date:  2017-09-02       Impact factor: 3.064

8.  Lower GrB+ CD62Lhigh CD8 TCM effector lymphocyte response to influenza virus in older adults is associated with increased CD28null CD8 T lymphocytes.

Authors:  Dongxu Xie; Janet E McElhaney
Journal:  Mech Ageing Dev       Date:  2007-05-22       Impact factor: 5.432

9.  Determination and Quantitation of Cytotoxic T Cell-Mediated Cell Death.

Authors:  Han-Hsuan Fu; Harry Qui
Journal:  Methods Mol Biol       Date:  2021

10.  Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunity.

Authors:  Adam D Cohen; Adi Diab; Miguel-Angel Perales; Jedd D Wolchok; Gabrielle Rizzuto; Taha Merghoub; Deonka Huggins; Cailian Liu; Mary Jo Turk; Nicholas P Restifo; Shimon Sakaguchi; Alan N Houghton
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.